Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJul 23, 2025Rizatriptan Benzoate TabletsCGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.Ascend Laboratories, LLC · D-0534-2025Class IIOngoingJul 23, 2025Rizatriptan Benzoate TabletsCGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.Ascend Laboratories, LLC · D-0533-2025Class IICompletedJul 23, 2025Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mgProduct Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a...Lupin Pharmaceuticals Inc. · D-0532-2025Class IIOngoingJul 23, 2025PERIPHERAL PARENTERAL NUTRITIONLack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles · D-0530-2025Class IIOngoingJul 23, 2025Omeprazole Delayed-release CapsulesPresence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.Dr. Reddy's Laboratories, Inc. · D-0525-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0524-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0523-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0522-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0521-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0520-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0519-2025Class IIOngoingJul 23, 2025Levothyroxine Sodium TabletsSubpotent Drug: Assay below the approved specificationAccord Healthcare, Inc. · D-0518-2025Class IIIOngoingJul 23, 2025Testosterone 200 mg PelletLabeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.Qualgen, LLC · D-0517-2025Class IIOngoingJul 23, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).Sun Pharmaceutical Industries Inc · D-0516-2025Class IIOngoingJul 16, 2025In Your Face Mineral Tint SPF 31cGMP deviationsKabana Skin Care · D-0515-2025Class IIOngoingJul 16, 2025GreenScreencGMP deviationsKabana Skin Care · D-0514-2025Class IIOngoingJul 16, 2025Erin's FacescGMP deviationsKabana Skin Care · D-0513-2025Class IIOngoingJul 16, 2025B Natural OrganicscGMP deviationsKabana Skin Care · D-0512-2025Class IIOngoingJul 16, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limitBreckenridge Pharmaceutical, Inc. · D-0511-2025Class IIIOngoingJul 16, 2025Famciclovir TabletsPresence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.Macleods Pharmaceuticals Ltd · D-0509-2025Class IOngoingJul 9, 2025Buffered Penicillin G Potassium for InjectionLabeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20 million UnitSandoz Inc · D-0570-2025Class IOngoingJul 9, 2025Cefazolin for InjectionLabeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit...Sandoz Inc · D-0569-2025Class IIIOngoingJul 9, 2025Pitavastatin TabletsFailed Impurity/Degradation SpecificationsAvKARE · D-0529-2025Class IIIOngoingJul 9, 2025Pitavastatin TabletsFailed Impurity/Degradation SpecificationsAvKARE · D-0528-2025Class IIIOngoingJul 9, 2025Pitavastatin TabletsFailed Impurities/Degradation Specifications.Orient Pharma Co., Ltd. Yunlin Plant · D-0527-2025Class IIIOngoingJul 9, 2025Pitavastatin TabletsFailed Impurities/Degradation Specifications.Orient Pharma Co., Ltd. Yunlin Plant · D-0526-2025Class IIOngoingJul 9, 2025Metoprolol Succinate Extended-Release TabletsFailed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.Granules Pharmaceuticals Inc. · D-0510-2025Class IIOngoingJul 9, 2025Gabapentin CapsulesDefective container; blister packaging inadequately sealed.The Harvard Drug Group LLC · D-0508-2025Class IIOngoingJul 9, 2025Gabapentin CapsulesDefective container; blister packaging inadequately sealed.The Harvard Drug Group LLC · D-0507-2025Class IOngoingJul 9, 2025Orajel BabyMicrobial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.Church & Dwight Inc · D-0506-2025Class IOngoingJul 9, 2025ZICAM NASAL ALLCLEARMicrobial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.Church & Dwight Inc · D-0505-2025Class IOngoingJul 9, 2025ZICAM COLD REMEDY MEDICATED NASAL SWABSMicrobial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.Church & Dwight Inc · D-0504-2025Class IIOngoingJul 9, 2025LIDOcaine HCL Sterile InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Tailstorm Health INC · D-0503-2025Class IIOngoingJul 9, 2025LIDOcaine HCL Sterile InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Tailstorm Health INC · D-0502-2025Class IIOngoingJul 9, 2025KETAmine Hydrochloride InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Tailstorm Health INC · D-0501-2025Class IIOngoingJul 9, 2025KETAmine Hydrochloride InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Tailstorm Health INC · D-0500-2025Class IIOngoingJul 9, 2025BUPIVAcaine HCL Sterile injectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Tailstorm Health INC · D-0499-2025Class IIOngoingJul 9, 2025LIDOcaine HCl InjectionLack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.Tailstorm Health INC · D-0498-2025Class IIOngoingJul 2, 2025TESTO-200Marketed Without an Approved NDA/ANDAAdvanced Pharmaceutical Technology, Inc. · D-0531-2025Class IIOngoingJul 2, 2025Brimonidine Tartrate/Timolol Maleate Ophthalmic SolutionLack of Assurance of SterilityApotex Corp. · D-0496-2025

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.